First-Line Antibiotics for Bacterial Bronchitis
For acute bacterial bronchitis in otherwise healthy adults, antibiotics should NOT be prescribed, as they provide no proven benefit and cause more harm than good. 1
However, the term "bacterial bronchitis" requires careful clinical distinction, as treatment recommendations differ dramatically based on the specific condition:
Acute Bronchitis in Healthy Adults
No antibiotics are indicated. 2, 1
- The American Thoracic Society explicitly recommends against antibiotic use in acute bronchitis for otherwise healthy adults, as clinical trials have not confirmed benefit versus placebo 1
- Antibiotics should only be considered if fever >38°C persists beyond 3 days, which suggests bacterial superinfection or pneumonia rather than simple acute bronchitis 1
- Purulent or discolored sputum (green/yellow) does NOT indicate bacterial infection and is not an indication for antibiotics 1
Common pitfall: Prescribing antibiotics based on sputum color alone is inappropriate and contributes to antimicrobial resistance 1
Acute Exacerbation of Chronic Bronchitis (COPD Exacerbation)
This is where antibiotics ARE indicated, but only in specific circumstances:
When to Prescribe Antibiotics
Antibiotics are recommended when at least 2 of 3 Anthonisen criteria are present: 2, 3, 1
- Increased sputum volume
- Increased sputum purulence
- Increased dyspnea
Exception: In patients with severe COPD (FEV1 <35%) or respiratory insufficiency, immediate antibiotic therapy is recommended during any exacerbation 1
First-Line Antibiotic Choices
Amoxicillin is the first-choice antibiotic for uncomplicated exacerbations in patients without risk factors (FEV1 ≥35%). 2, 3, 1
- Dosing: 3 g/day in divided doses 2
- This recommendation is based on WHO guidelines, NICE, and multiple international societies 2
Alternative first-line options include: 2, 1
- Doxycycline - particularly useful in penicillin allergy 2
- Macrolides (azithromycin, clarithromycin) - especially for penicillin-allergic patients 2
- First-generation cephalosporins (cefalexin) - though note this is specifically for COPD exacerbations, NOT for other respiratory infections 2
Second-Line Antibiotic Choices
For complicated exacerbations or treatment failure, second-line options include: 2
- Amoxicillin-clavulanate - the reference second-line therapy 2, 1
- Second-generation cephalosporins (cefuroxime-axetil) 2, 1
- Third-generation cephalosporins (cefpodoxime-proxetil, cefotiam-hexetil, but NOT cefixime) 2, 1
Fluoroquinolones: Use with Extreme Caution
Fluoroquinolones (levofloxacin, moxifloxacin) should NOT be used as first-line therapy for bacterial bronchitis. 2
- The FDA issued a boxed warning in 2016 against using fluoroquinolones for acute bacterial exacerbation of chronic bronchitis due to disabling and potentially permanent side effects affecting tendons, muscles, joints, and peripheral/central nervous systems 2
- These agents should be reserved only for life-threatening infections where benefit outweighs risk 2
- The WHO Working Group explicitly excluded fluoroquinolones from recommendations due to side effects and resistance emergence 2
Treatment Duration
Standard treatment duration is 5-8 days for acute exacerbations. 2
- For COPD exacerbations specifically, at least 7 days of treatment is recommended 3
- Clinical reassessment should occur after 5-7 days 3
- Fever should resolve within 2-3 days; persistence beyond 3 days suggests treatment failure or incorrect diagnosis 3
Critical Clinical Algorithm
Step 1: Determine if this is acute bronchitis in a healthy adult or COPD exacerbation
- If healthy adult with acute bronchitis → No antibiotics 1
- If COPD patient → Proceed to Step 2
Step 2: Assess Anthonisen criteria (for COPD patients)
- If <2 criteria present → No antibiotics (unless FEV1 <35%) 2, 3
- If ≥2 criteria present → Proceed to Step 3
Step 3: Assess severity and risk factors
- If FEV1 ≥35%, no complications → Amoxicillin 3 g/day 2, 3
- If penicillin allergy → Doxycycline or macrolide 2
- If treatment failure or complicated → Amoxicillin-clavulanate 2
Step 4: Reassess at 2-3 days